The latest data point for RXRX's EPS Diluted in Q1'26 is -0.22 USD, marking a modest worsening from the previous quarter's -0.17 USD in Q4'25 but still reflecting ongoing losses. This value indicates continued negative earnings per share, though the magnitude remains relatively contained compared to earlier periods. Over the period from Q2'23 to Q1'26, EPS Diluted has shown a volatile yet gradually improving trend, starting at -0.38 USD and fluctuating between -0.57 USD (Q4'24 low) and -0.17 USD (Q4'25 high), with an overall shift toward less severe losses in recent quarters. Year-over-year EPS Growth has been inconsistent, dipping to -40% in Q4'23 before turning positive at 21% in Q3'24 and surging to 70% in Q4'25, suggesting accelerating improvement in earnings performance despite persistent negativity. The bar chart visualization highlights these quarterly dips and recoveries, while the overlaid line for growth underscores potential momentum toward profitability.